ARTICLE | Clinical News
Eli Lilly preclinical data
April 23, 2012 7:00 AM UTC
In animal xenograft models of c-Met-amplified NSCLC, LY2875358 alone displayed antitumor activity. Additionally, LY2875358 in combination with chemotherapy displayed better antitumor activity than eit...